While performing heart bypass surgery, SPY-Q enables cardiac surgeons using Novadaq’s SPY imaging system to objectively measure increases in fluorescence by comparing pre- and post-bypass images, the company said.
The SPY-Q post-processing software analysis tools will be sold as an upgrade to the SPY imaging system. While SPY-Q is ideal for use during cardiac surgery, it was also developed for use in other surgical specialties.
Novadaq believes that SPY-Q may significantly advance surgical procedures such as breast reconstruction, where adequate tissue perfusion is critical to achieving optimal outcomes and reducing the potential for costly and emotionally devastating post-operative complications.
Rick Mangat, senior vice president and general manager of Novadaq, said: “SPY-Q was developed as a result of direct feedback from our surgeon customers. These surgeons rapidly recognized that SPY imaging positively contributed to surgical decision making and post-operative outcomes for patients.”